These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6331882)

  • 1. Phase I-II trial of high-dose calcium leucovorin and 5-fluorouracil in advanced colorectal cancer.
    Madajewicz S; Petrelli N; Rustum YM; Campbell J; Herrera L; Mittelman A; Perry A; Creaven PJ
    Cancer Res; 1984 Oct; 44(10):4667-9. PubMed ID: 6331882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the Fas signaling pathway by IFN-gamma in therapy of colon cancer: phase I trial and correlative studies of IFN-gamma, 5-fluorouracil, and leucovorin.
    Schwartzberg LS; Petak I; Stewart C; Turner PK; Ashley J; Tillman DM; Douglas L; Tan M; Billups C; Mihalik R; Weir A; Tauer K; Shope S; Houghton JA
    Clin Cancer Res; 2002 Aug; 8(8):2488-98. PubMed ID: 12171874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers.
    Yeh KH; Cheng AL; Lin MT; Hong RL; Hsu CH; Lin JF; Chang KJ; Lee PH; Chen YC
    Anticancer Res; 1997; 17(5B):3867-71. PubMed ID: 9427794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schedule-selective biochemical modulation of 5-fluorouracil: a phase II study in advanced colorectal cancer.
    Sobrero AF; Aschele C; Guglielmi AP; Mori AM; Tixi LM; Bolli EA; Rosso R; Mammoliti S; Rollandi GA; Bertoglio S
    Clin Cancer Res; 1995 Sep; 1(9):955-60. PubMed ID: 9816066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II evaluation of metoprine with leucovorin rescue in patients with advanced colorectal carcinoma.
    Lynch G; Currie V; Kemeny N
    Cancer Clin Trials; 1981; 4(3):281-3. PubMed ID: 6974612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy.
    Doroshow JH; Multhauf P; Leong L; Margolin K; Litchfield T; Akman S; Carr B; Bertrand M; Goldberg D; Blayney D
    J Clin Oncol; 1990 Mar; 8(3):491-501. PubMed ID: 2407810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I and pharmacokinetic studies of high-dose uridine intended for rescue from 5-fluorouracil toxicity.
    Leyva A; van Groeningen CJ; Kraal I; Gall H; Peters GJ; Lankelma J; Pinedo HM
    Cancer Res; 1984 Dec; 44(12 Pt 1):5928-33. PubMed ID: 6498850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
    Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević A
    Srp Arh Celok Lek; 1998; 126(9-10):355-61. PubMed ID: 9863407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
    Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma and tumor tissue pharmacology of high-dose intravenous leucovorin calcium in combination with fluorouracil in patients with advanced colorectal carcinoma.
    Trave F; Rustum YM; Petrelli NJ; Herrera L; Mittelman A; Frank C; Creaven PJ
    J Clin Oncol; 1988 Jul; 6(7):1184-91. PubMed ID: 3260621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacological studies of concurrent infusion of 5-fluorouracil and thymidine in treatment of colorectal carcinomas.
    Au JL; Rustum YM; Ledesma EJ; Mittelman A; Creaven PJ
    Cancer Res; 1982 Jul; 42(7):2930-7. PubMed ID: 6211226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UFT/leucovorin and mitomycin C as salvage treatment in patients with advanced colorectal cancer - a retrospective analysis.
    Vormittag L; Kornek GV; Gruhsmann B; Lenauer A; Föger A; Depisch D; Lang F; Scheithauer W
    Anticancer Drugs; 2007 Jul; 18(6):709-12. PubMed ID: 17762401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Phase I trial of preoperative eniluracil plus 5-fluorouracil and radiation for locally advanced or unresectable adenocarcinoma of the rectum and colon.
    Czito BG; Hong TJ; Cohen DP; Tyler DS; Lee CG; Anscher MS; Ludwig KA; Seigler HF; Mantyh C; Morse MA; Lockhart AC; Petros WP; Honeycutt W; Spector NL; Ertel PJ; Mangum SG; Hurwitz HI
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):779-85. PubMed ID: 14967434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study.
    Hong RL; Sheen TS; Ko JY; Hsu MM; Wang CC; Ting LL
    Br J Cancer; 1999 Aug; 80(12):1962-7. PubMed ID: 10471046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical modulation in the treatment of advanced cancer: a study of combined leucovorin, fluorouracil, and iododeoxyuridine.
    Marshall JL; Richmond E; DeLap RJ
    Clin Cancer Res; 1996 Sep; 2(9):1475-80. PubMed ID: 9816323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability of high-dose oral leucovorin.
    Hines JD; Zakem MH; Adelstein DJ; Giroski P; Blum MR; Rustum YM
    NCI Monogr; 1987; (5):57-60. PubMed ID: 3501547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Spanish experience with high-dose infusional 5-fluorouracil (5-FU) in colorectal cancer. The Spanish Cooperative Group For Gastrointestinal Tumor Therapy (TTD).
    Aranda E; Cervantes A; Carrato A; Antón-Torres A; Massutí T; Fernández-Martos C; Díaz-Rubio E
    J Infus Chemother; 1996; 6(3):118-22. PubMed ID: 9229321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer.
    Kemeny N; Garay CA; Gurtler J; Hochster H; Kennedy P; Benson A; Brandt DS; Polikoff J; Wertheim M; Shumaker G; Hallman D; Burger B; Gupta S
    J Clin Oncol; 2004 Dec; 22(23):4753-61. PubMed ID: 15570076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary analysis of a randomized comparison of 5-fluorouracil versus 5-fluorouracil and high-dose continuous-infusion folinic acid in disseminated colorectal cancer.
    Doroshow JH; Bertrand M; Newman E; Multhauf P; Leong L; Blayney D; Goldberg D; Margolin K; Carr B; Akman S
    NCI Monogr; 1987; (5):171-4. PubMed ID: 3501538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of aminothiadiazole in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial.
    Locker GY; Khandekar J; Krauss S; Reisel H; Hoeltgen T; Wolter J; Haid M; Hoffman R; Blough R; Johnson C
    Cancer Treat Rep; 1987 Jun; 71(6):649-50. PubMed ID: 3555791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.